RITE AID CORP (RAD) Stock Price, Forecast & Analysis
USA - NYSE:RAD - US7677548726 - Common Stock
RAD Key Statistics, Chart & Performance
The current stock price of RAD is 0.6483 USD. In the past month the price decreased by -2.92%. In the past year, price decreased by -83.2%.
RAD Latest News, Press Relases and Analysis
RAD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GRDN | GUARDIAN PHRMCY SERVICES-A | N/A | 1.85B | ||
| MGRX | MANGOCEUTICALS INC | N/A | 15.60M | ||
| SRXH | SRX HEALTH SOLUTIONS INC | N/A | 6.09M |
Related stock screener links
About RAD
Company Profile
Rite Aid Corp. engages in the ownership and management of retail drug stores. The company is headquartered in Philadelphia, Pennsylvania and currently employs 47,000 full-time employees. The firm is engaged in providing its services to customers and communities through various programs. The company operates through two segments: the Retail Pharmacy segment and the Pharmacy Services segment. The Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. The Pharmacy Services Segment, which consists of Elixir, its pharmacy benefit management (PBM) business, provides a suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network, and rebate administration, claims adjudication, and pharmacy discount programs. Elixir also provides prescription discount programs and Medicare Part D insurance offerings for individuals and groups. The company operates over 2,300 retail pharmacy locations across 17 states.
Company Info
RITE AID CORP
1200 Intrepid Avenue, 2nd Floor
PHILADELPHIA PENNSYLVANIA 17011 US
CEO: Heyward Donigan
Employees: 47000
Phone: 17177612633.0
RITE AID CORP / RAD FAQ
What does RITE AID CORP do?
Rite Aid Corp. engages in the ownership and management of retail drug stores. The company is headquartered in Philadelphia, Pennsylvania and currently employs 47,000 full-time employees. The firm is engaged in providing its services to customers and communities through various programs. The company operates through two segments: the Retail Pharmacy segment and the Pharmacy Services segment. The Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. The Pharmacy Services Segment, which consists of Elixir, its pharmacy benefit management (PBM) business, provides a suite of PBM offerings including technology solutions, mail delivery services, specialty pharmacy, network, and rebate administration, claims adjudication, and pharmacy discount programs. Elixir also provides prescription discount programs and Medicare Part D insurance offerings for individuals and groups. The company operates over 2,300 retail pharmacy locations across 17 states.
What is the stock price of RITE AID CORP today?
The current stock price of RAD is 0.6483 USD. The price decreased by -16.81% in the last trading session.
What is the dividend status of RITE AID CORP?
RAD does not pay a dividend.
What is the ChartMill technical and fundamental rating of RAD stock?
RAD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is RITE AID CORP (RAD) stock traded?
RAD stock is listed on the New York Stock Exchange, Inc. exchange.
What is RITE AID CORP worth?
RITE AID CORP (RAD) has a market capitalization of 36.76M USD. This makes RAD a Nano Cap stock.
What is the ownership structure of RITE AID CORP (RAD)?
You can find the ownership structure of RITE AID CORP (RAD) on the Ownership tab.
RAD Technical Analysis
RAD Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to RAD. RAD has a bad profitability rating. Also its financial health evaluation is rather negative.
RAD Financial Highlights
Over the last trailing twelve months RAD reported a non-GAAP Earnings per Share(EPS) of -2.74. The EPS decreased by -10.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.37% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
RAD Forecast & Estimates
10 analysts have analysed RAD and the average price target is 1.02 USD. This implies a price increase of 57.33% is expected in the next year compared to the current price of 0.6483.
For the next year, analysts expect an EPS growth of -86.91% and a revenue growth -3.31% for RAD